Additionally, Yao et al. demonstrated that IL-6 upregulation mediated by TGF-β signal pathway conferred NSCLC cell drug resistance in an EGFR independent manner and promoted NSCLC cell proliferation9. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.